A detailed history of Susquehanna International Group, LLP transactions in Evolus, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 15,868 shares of EOLS stock, worth $270,073. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,868
Previous 298,358 94.68%
Holding current value
$270,073
Previous $4.18 Million 95.88%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$10.45 - $13.76 $2.95 Million - $3.89 Million
-282,490 Reduced 94.68%
15,868 $172,000
Q1 2024

May 07, 2024

BUY
$9.99 - $14.91 $2.84 Million - $4.23 Million
283,962 Added 1972.51%
298,358 $4.18 Million
Q4 2023

Feb 14, 2024

SELL
$7.6 - $10.53 $31,441 - $43,562
-4,137 Reduced 22.32%
14,396 $151,000
Q3 2023

Nov 14, 2023

SELL
$7.15 - $10.2 $83,118 - $118,574
-11,625 Reduced 38.55%
18,533 $169,000
Q2 2023

Aug 11, 2023

BUY
$7.23 - $10.52 $22,376 - $32,559
3,095 Added 11.44%
30,158 $219,000
Q1 2023

May 16, 2023

BUY
$7.81 - $11.05 $94,907 - $134,279
12,152 Added 81.5%
27,063 $228,000
Q4 2022

Feb 14, 2023

SELL
$6.52 - $8.95 $212,982 - $292,360
-32,666 Reduced 68.66%
14,911 $111,000
Q3 2022

Nov 14, 2022

BUY
$7.76 - $13.72 $369,197 - $652,756
47,577 New
47,577 $383,000
Q4 2021

Feb 14, 2022

SELL
$5.37 - $8.38 $259,494 - $404,946
-48,323 Reduced 25.01%
144,908 $943,000
Q3 2021

Nov 15, 2021

SELL
$7.36 - $13.67 $762,113 - $1.42 Million
-103,548 Reduced 34.89%
193,231 $1.47 Million
Q2 2021

Aug 11, 2021

BUY
$8.42 - $13.96 $1.78 Million - $2.95 Million
211,250 Added 246.99%
296,779 $3.75 Million
Q1 2021

May 17, 2021

SELL
$3.2 - $16.51 $685,772 - $3.54 Million
-214,304 Reduced 71.47%
85,529 $1.11 Million
Q4 2020

Feb 16, 2021

BUY
$2.92 - $4.84 $696,160 - $1.15 Million
238,411 Added 388.15%
299,833 $1.01 Million
Q3 2020

Nov 16, 2020

SELL
$3.03 - $5.48 $40,935 - $74,034
-13,510 Reduced 18.03%
61,422 $240,000
Q2 2020

Aug 14, 2020

BUY
$3.53 - $6.17 $89,386 - $156,236
25,322 Added 51.04%
74,932 $397,000
Q1 2020

May 15, 2020

SELL
$3.53 - $12.21 $120,775 - $417,752
-34,214 Reduced 40.82%
49,610 $206,000
Q4 2019

Feb 14, 2020

SELL
$11.58 - $17.37 $495,635 - $743,453
-42,801 Reduced 33.8%
83,824 $1.02 Million
Q3 2019

Nov 14, 2019

BUY
$13.91 - $19.87 $839,468 - $1.2 Million
60,350 Added 91.06%
126,625 $1.98 Million
Q2 2019

Aug 16, 2019

BUY
$13.19 - $28.36 $49,449 - $106,321
3,749 Added 6.0%
66,275 $969,000
Q2 2019

Aug 14, 2019

SELL
$13.19 - $28.36 $1.08 Million - $2.32 Million
-81,760 Reduced 56.67%
62,526 $914,000
Q1 2019

May 15, 2019

BUY
$12.43 - $28.91 $1.29 Million - $3 Million
103,855 Added 256.87%
144,286 $3.26 Million
Q4 2018

Feb 14, 2019

BUY
$10.57 - $19.29 $427,355 - $779,913
40,431 New
40,431 $481,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $955M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.